BTIG Downgrades Outlook Therapeutics Incs. (OTLK) to Neutral

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. AMGN
3. BKNG
4. DOX
5. DUOL
6. ANET
7. SWKS
8. XYZ
9. FISV
10. CVS

Go back to BTIG Downgrades Outlook Therapeutics Incs. (OTLK) to Neutral

Outlook Therapeutics (OTLK) Receives CRL for ONS-5010

August 30, 2023 6:00 AM EDT

Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve FDA approval for the first ophthalmic formulation of bevacizumab for the treatment of retinal diseases, today announced the U.S. Food and Drug Administration (FDA) has issued a CRL to the Companys BLA for ONS-5010, an investigational ophthalmic formulation of bevacizumab under development to... More